Andreessen Horowitz's Biotechnology Portfolio

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.

Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Apeel Sciences develops plant-derived shelf life extension technology for fresh produce that improves quality and reduces food waste.

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Inductive Bio provides the information, machine learning, tools, and know-how required to resolve ADMET issues.

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

Ultima Genomics is a developer of a low-cost sequencing platform.

Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Deepcell is a life science company specializing in AI-powered single-cell classification and isolation for basic and translational research.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

Phylo provides an integrated workspace with AI-assisted tools to support planning, execution, and review of biological research.

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Earli develops genetic constructs for early cancer detection and targeted therapy.

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone

Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

Elegen is a biotechnology company that develops microfluidic technology.

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.

Boltz PBC develops open-source AI models and software platforms for biomolecular design.